Is ICU treatment cost effective?

Download Is ICU treatment cost effective?

Post on 22-Mar-2017

212 views

Category:

Documents

0 download

Embed Size (px)

TRANSCRIPT

<ul><li><p>PHARMACOECONOMICS </p><p>Is lCU treatment cost effective? It would seem that leu treatment is cost effective, </p><p>according to the findings of an Australian study. The data showed that the cost/quality-adjusted life-year (QALY) associated with treatment at a general hospital intensive care unit (leU) in Sydney, Australia, was 'less than 10% of that for some commonly accepted medical interventions'. </p><p>The study authors investigated 248 leu admissions at the hospital during a 6-month period in 1986. Patients were followed for 3 years and completed a health questionnaire and the YorkIRosser Index quality-of-life (QOL) questionnaire.* </p><p>During the 3-year period, 63% of patients were readmitted to hospital and 79% received medication. Personal health status was described as 'excellent' by 4% of patients, 'good' by 27%, 'satisfactory' by 25%, 'fair' by 29%, 'poor' by 12% and 'terrible' by 3%. QOL for long-term survivors was 'generally good', with little difference between diagnostic groups. After 3 years, 150 patients were still alive. </p><p>Treatment costs during initial hospitalisation did not correlate with long-term outcome, as measured by quality-adjusted life-years (QALYs). Also, costs and outcomes 'varied markedly' between diagnostic groups. Treatment was most cost effective in patients with asthma and least cost effective in those with pulmonary oedema [see table]. The cost/QALY associated with leu treatment compared favourably with the range of cost-effectiveness ratios seen for some commonly accepted interventions; e.g. from $A4596 for renal transplantation to $A130 000 for zidovudine therapy in patients with AIDS. * The YorWRosser Index QOL questionnaire enables assessment of paIient disability and distress. Kerridge RK, Glasziou Pp, HiJlman KM. The use of quality-adjusted life years (QALYs) to evaluate treannent in intensive care. Anaesthesia and Intensive Care 23: 322-331, ]un 1995 80036&gt;783 </p><p>0156-270319510995-00071$01.00 Adl. International Umlted 1995. All rlghta reaervad </p><p>.7 </p><p>INPHARMA"'15 Ju11995 </p><p>PHARMACOECONOMICS </p><p>Is lCU treatment cost effective? It would seem that leu treatment is cost effective, </p><p>according to the findings of an Australian study. The data showed that the cost/quality-adjusted life-year (QALY) associated with treatment at a general hospital intensive care unit (leU) in Sydney, Australia, was 'less than 10% of that for some commonly accepted medical interventions'. </p><p>The study authors investigated 248 leu admissions at the hospital during a 6-month period in 1986. Patients were followed for 3 years and completed a health questionnaire and the YorkIRosser Index quality-of-life (QOL) questionnaire.* </p><p>During the 3-year period, 63% of patients were readmitted to hospital and 79% received medication. Personal health status was described as 'excellent' by 4% of patients, 'good' by 27%, 'satisfactory' by 25%, 'fair' by 29%, 'poor' by 12% and 'terrible' by 3%. QOL for long-term survivors was 'generally good', with little difference between diagnostic groups. After 3 years, 150 patients were still alive. </p><p>Treatment costs during initial hospitalisation did not correlate with long-term outcome, as measured by quality-adjusted life-years (QALYs). Also, costs and outcomes 'varied markedly' between diagnostic groups. Treatment was most cost effective in patients with asthma and least cost effective in those with pulmonary oedema [see table]. The cost/QALY associated with leu treatment compared favourably with the range of cost-effectiveness ratios seen for some commonly accepted interventions; e.g. from $A4596 for renal transplantation to $A130 000 for zidovudine therapy in patients with AIDS. * The YorWRosser Index QOL questionnaire enables assessment of paIient disability and distress. Kerridge RK, Glasziou Pp, HiJlman KM. The use of quality-adjusted life years (QALYs) to evaluate treannent in intensive care. Anaesthesia and Intensive Care 23: 322-331, ]un 1995 80036&gt;783 </p><p>0156-270319510995-00071$01.00 Adl. International Umlted 1995. All rlghta reaervad </p><p>.7 </p><p>INPHARMA"'15 Ju11995 </p><p> /ColorImageDict &gt; /JPEG2000ColorACSImageDict &gt; /JPEG2000ColorImageDict &gt; /AntiAliasGrayImages false /CropGrayImages true /GrayImageMinResolution 150 /GrayImageMinResolutionPolicy /Warning /DownsampleGrayImages true /GrayImageDownsampleType /Bicubic /GrayImageResolution 150 /GrayImageDepth -1 /GrayImageMinDownsampleDepth 2 /GrayImageDownsampleThreshold 1.50000 /EncodeGrayImages true /GrayImageFilter /DCTEncode /AutoFilterGrayImages true /GrayImageAutoFilterStrategy /JPEG /GrayACSImageDict &gt; /GrayImageDict &gt; /JPEG2000GrayACSImageDict &gt; /JPEG2000GrayImageDict &gt; /AntiAliasMonoImages false /CropMonoImages true /MonoImageMinResolution 599 /MonoImageMinResolutionPolicy /Warning /DownsampleMonoImages true /MonoImageDownsampleType /Bicubic /MonoImageResolution 600 /MonoImageDepth -1 /MonoImageDownsampleThreshold 1.50000 /EncodeMonoImages true /MonoImageFilter /CCITTFaxEncode /MonoImageDict &gt; /AllowPSXObjects false /CheckCompliance [ /PDFA1B:2005 ] /PDFX1aCheck false /PDFX3Check false /PDFXCompliantPDFOnly false /PDFXNoTrimBoxError true /PDFXTrimBoxToMediaBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXSetBleedBoxToMediaBox true /PDFXBleedBoxToTrimBoxOffset [ 0.00000 0.00000 0.00000 0.00000 ] /PDFXOutputIntentProfile (sRGB IEC61966-2.1) /PDFXOutputConditionIdentifier () /PDFXOutputCondition () /PDFXRegistryName () /PDFXTrapped /False</p><p> /CreateJDFFile false /Description &gt;&gt;&gt; setdistillerparams&gt; setpagedevice</p></li></ul>